DECTOVA

This brand name is authorized in Austria, Estonia, Finland, France, Croatia, Ireland, Lithuania, Netherlands, Poland, United Kingdom

Active ingredients

The drug DECTOVA contains one active pharmaceutical ingredient (API):

1 Zanamivir UNII L6O3XI777I - ZANAMIVIR

Zanamivir is an inhibitor of influenza virus neuraminidase, an enzyme that releases viral particles from the plasma membrane of infected cells and promotes virus spread in the respiratory tract. The activity of zanamivir is extracellular. It reduces the propagation of both influenza A and B viruses by inhibiting the release of infectious influenza virions from the epithelial cells of the respiratory tract. Read about Zanamivir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DECTOVA Solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AH01	Zanamivir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AH Neuraminidase inhibitors
Discover more medicines within J05AH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1795754, 1874246
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 395010
Country: FR	Base de données publique des médicaments	Identifier(s): 64427189
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 378891
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1087663
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 199818
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100420087